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 Obesity is an increasingly prevalent health problem, 
very often accompanied by other diseases, the most com-
mon being insulin resistance, type 2 diabetes mellitus, 
and cardiovascular complications ( 1, 2 ). Furthermore, 
an association has been reported between obesity and 
both oxidative stress and increased infl ammation ( 3, 4 ). 
Obesity facilitates the development of a low-grade in-
fl ammatory state, characterized by increased plasma lev-
els of proinfl ammatory cytokines ( 4 ). However, the factors 
that trigger this low-grade infl ammation in obesity are 
unclear. Postprandial lipidemia has recently emerged 
as a potential candidate because the ingestion of a high-
fat meal leads to the systemic increase of a wide range 
of infl ammatory mediators ( 5–7 ) and an increase in oxi-
dative stress markers ( 8 ). However, the cause of these 
postprandial events that occur in association with the 
postprandial triglyceride response remains poorly un-
derstood. A possible link is bacterial endotoxin [lipopoly-
saccharide (LPS)], a component of the Gram-negative 
bacteria cell wall that is present in large quantities in 
the human gut ( 9 ). Endotoxins circulate in the plasma 
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 MATERIAL AND METHODS 
 Subjects and study design 
 A total of 40 morbidly obese patients [body mass index (BMI) 
>40 kg/m 2 ] were selected from our database according to their 
degree of insulin resistance (HOMA-IR): 20 morbidly obese 
patients with HOMA-IR < 5 and 20 morbidly obese patients 
with HOMA-IR > 8. Those patients with intermediate values 
of HOMA-IR (HOMA-IR > 5 or < 8) were excluded. The cut-off 
point for the HOMA-IR was taken from previous studies carried 
out in a healthy population with no carbohydrate metabolism dis-
orders ( 2 ). Patients were excluded if they had cardiovascular dis-
ease, arthritis, acute infl ammatory disease, infectious disease, 
renal disease, were receiving treatment for hyperlipidemia or dia-
betes or were taking medications that could infl uence gastric 
emptying or the absorption time. All the patients were recruited 
by endocrinologists and gave informed consent to the study, 
which was approved by the Ethics Committee of Virgen de la Vic-
toria Clinical University Hospital, Malaga, Spain. 
 After an overnight fast, all 40 participants underwent a 50 g 
fat overload with a preparation (patent No. P201030776). Only 
water was permitted during the process and no physical exercise 
was undertaken. The preparation of 100 ml contained 50 g fat, 
of which 10 g were saturated, 29.46 g were monounsaturated, 
and 10.625 g were polyunsaturated. Each 100 ml contained <1 g 
lauric acid, <1 g myristic acid, 4.8 g palmitic acid, 1.4 g stearic 
acid, 27.7 g oleic acid, 9.6 g linoleic acid, 1.4 g behenic acid 
and 0.5 g lignoceric acid. This test was previously validated in 
another study by our group ( 19 ). All the participants followed 
the same diet on the day prior to fat overload. 
 The 40 patients were classifi ed according to their degree of 
insulin resistance (HOMA-IR, calculated as described below) 
and the Delta triglycerides (  TG), measured as the difference 
of healthy human subjects at low concentrations (known 
as metabolic endotoxemia), and an elevated concentra-
tion of circulating LPS has been associated with a higher 
risk for atherosclerosis ( 10 ). There is evidence that met-
abolic plasma LPS levels are modulated by food content: 
the higher the fat content, the higher the concentration 
of plasma LPS ( 11 ). Small amounts of LPS are absorbed 
from the gut in healthy animals ( 12 ), and there is evi-
dence that chylomicrons likely also transport signifi cant 
amounts of absorbed gut LPS ( 13–15 ). In concordance 
with these data, some studies have shown that a high-fat 
meal leads to an increase in postprandial endotoxemia 
( 7, 14 ). 
 Obesity tends to be accompanied by the consumption 
of a high-fat diet, and interestingly, the proportion of 
Gram-negative bacteria in microfl ora is higher in obese 
subjects than in lean subjects ( 16, 17 ). Thus, these condi-
tions would enhance the translocation of endogenous LPS 
from the gut during fat absorption, which would lead to 
the low-grade infl ammation observed in these patients ( 7, 
18 ). However, no studies have yet examined metabolic en-
dotoxemia in obese patients. This is of particular interest, 
as metabolic endotoxemia could be involved in the devel-
opment of obesity-related comorbidities, as it has been as-
sociated with the development of insulin resistance in 
mice ( 18 ). 
 Thus, the aim of this study was to analyze postprandial 
endotoxemia in morbidly obese patients after a fat over-
load and to determine its relationship with postprandial 
hypertriglyceridemia and insulin resistance. 
 TABLE 1. Anthropometric and biochemical variables of the study groups 
Group 1 (n = 10) Group 2 (n = 10) Group 3 (n = 10) Group 4 (n = 10) All (n = 40)
Age (years) 40.00 ± 11.58a 38.71 ± 8.63a 43.14 ± 6.568a 42.00 ± 6.00a 41.41 ± 9.36
Weight (Kg) 129.77 ± 27.50a, b 152.64 ± 23.90b, c 118.96 ± 11.93a 156.95 ± 11.29c 139.38 ± 25.48
BMI (kg/m 2 ) 51.69 ± 9.16a, b 59.85 ± 8.86a 46,66 ± 6.54b 55,72 ± 9.56a, b 53.70 ± 9.49
Waist (cm) 130.05 ± 10.63a 147.29 ± 14.64b 123.00 ± 5.66a 152.00 ± 7.80b 137.80 ± 15.24
Hip (cm) 147.40 ± 12.62a 155.14 ± 10.24a 145.20 ± 11.28a 149.17 ± 16.52a 149.32 ± 12.61
Waist/Hip ratio 0.88 ± 0.08a, b 0.95 ± 0.04b, c 0.85 ± 0.05a 1.03 ± 0.10c 0.92 ± 0.09
Glucose (mg/dl) 93.00 ± 16.32a 110.43 ± 26.25a 96.20 ± 6.94a 103.33 ± 11.22a 100.14 ± 17.99
Insulin (µUI/ml) 15.86 ± 5.54a 39.77 ± 9.74b 12.38 ± 2.33a 42.52 ± 8.21b 26.93 ± 15.03
HOMA-IR 3.59 ± 1.15a 10.54 ± 2.01b 2.94 ± 0.64a 10.79 ± 2.19b 6.76 ± 4.00
Uric acid (mg/dl) 5.85 ± 1.60a, b 6.33 ± 1.37a 5.27 ± 1.07a, b 7.20 ± 1.98b 6.16 ± 1.61
Chol (mg/dl) 211.40 ± 31.18a 187.57 ± 44.02a 183.00 ± 37.50a 183.50 ± 27.85a 194.39 ± 35.73
FFA 0 h (mmol/L) 0.52 ± 0.20a 0.55 ± 0.21a 0.42 ± 0.16a 0.49 ± 0.17a 0.51 ± 0.19
FFA 3 h (mmol/L) 0.74 ± 0.27a 0.74 ± 0.20a 0.77 ± 0.26a 0.83 ± 0.25a 0.76 ± 0.25
TG 0 h (mg/dl) 133.97 ± 77.15a, b 215.29 ± 105.69a 98.93 ± 46.93b 110.40 ± 19.80a 142.99 ± 82.74
TG 3 h (mg/dl) 166.75 ± 70.17a 251.00 ± 106.27a 205.21 ± 43.95a 224.29 ± 29.87a 207.01 ± 75.97
  TG (mg/dl) 32.78 ± 22.99a 35.71 ± 22.82a 106.28 ± 29.32b 113.88 ± 31.06b 64.02 ± 45.28
HDL-C (mg/dl) 48.20 ± 5.43a 41.14 ± 6.94a, b 45.80 ± 11.08a, b 37.83 ± 5.84b 43.79 ± 7.92
LDL (mg/dl) 140.71 ± 22.43a 98.80 ± 24.92b 105.71 ± 22.31a, b 123.95 ± 19.24a, b 120.30 ± 26.16
GOT (units/L) 26.30 ± 25.95a 19.86 ± 7.47a 20.00 ± 7.87a 34.67 ± 23.50a 25.36 ± 19.52
GGT (units/L) 27.30 ± 11.73a 26.43 ± 11.34a 26.00 ± 9.14a 51.33 ± 29.66b 32.00 ± 18.86
Leptin (ng/ml) 61.17 ± 32.94a 58.05 ± 23.28a 52.63 ± 29.28a 71.47 ± 25.87a 60.71 ± 29.39
Adiponectin (ng/ml) 9.35 ± 3.25a 6.85 ± 3.33a 9.49 ± 3.12a 7.49 ± 4.01a 8.52 ± 3.49
CRP 0 h (mg/dl) 6.15 ± 6.67a, b 10.09 ± 10.70a 3.98 ± 3.94b 7.42 ± 6.03a, b 7.03 ± 7.60
CRP 3 h (mg/dl) 5.11 ± 3.93a 8.43 ± 9.67a 3.86 ± 2.94a 7.38 ± 5.64a 6.11 ± 6.13
Values are presented as means ± SD. Different letters indicate signifi cant differences ( P < 0.05) between the study groups (ANOVA, Bonferoni 
test). Group 1: Patients with HOMA-IR   5 and   TG < 80 mg/dl; Group 2: patients with HOMA-IR > 8 and   TG < 80 mg/dl; Group 3: patients with 
HOMA-IR   5 and   TG > 80 mg/dl; Group 4: patients with HOMA-IR > 8 and   TG > 80 mg/dl. BMI, body mass index; HOMA-IR, homeostasis 
model assessment of insulin resistance; Chol, cholesterol; FFA, free fatty acids; TG, triglycerides;   TG, difference between postprandial and baseline 
triglyceride levels ; GOT, glutamic oxalacetic transaminase; GGT,   -glutamyltransferase; CRP, C-reactive protein.
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and heated at 70°C for 10 min to inactivate endotoxin-neutraliz-
ing agents that inhibit the activity of endotoxin in the LAL assay. 
Then, Pyrosperse reagent (Lonza Group Ltd.), a metallo-modi-
fi ed polyanionic dispersant, was added to the test samples at a 
ratio of 1/200 (v/v) before LAL testing to minimize interference 
in the reaction. Internal control of recovery calculation was in-
cluded in the assessment. All samples were tested in duplicate 
and results were accepted when the intra-assay CV was less than 
10%. The endotoxin content was expressed as endotoxin units 
(EU) per ml. Exhaustive care was taken to avoid environmental 
endotoxin contamination and all material used for sample prep-
aration and the test was pyrogen-free. 
 Statistical analysis 
 Study groups were compared by ANOVA and Bonferroni’s post-
hoc tests at both baseline and in the postprandial state. Analysis of 
the effects of the fat overload on the biological variables was done by 
Wilcoxon test. Spearman correlation analyses were done to study 
the associations between variables. Multiple linear regression analy-
sis was performed to evaluate which variables contributed more to 
LPS levels. In all cases, the rejection level for a null hypothesis was an 
alpha = 0.05 for two tails. Calculations were performed with SPSS 
software (version 15.0; SPSS Iberica, Madrid, Spain). 
 RESULTS 
 The anthropometric and biochemical variables of the 
morbidly obese patients are summarized in  Table 1 . 
 Plasma CRP levels were signifi cantly higher in group 2 
than in group 3, but there was no signifi cant difference 
between postprandial CRP levels ( Table 1 ). 
between postprandial triglycerides and baseline triglycerides, 
as follows: Group 1 (HOMA-IR   5 and   TG < 80 mg/dl), Group 
2 (HOMA-IR > 8 and   TG < 80 mg/dl), Group 3 (HOMA-IR   5 
and   TG > 80 mg/dl) and Group 4 (HOMA-IR > 8 and   TG > 80 
mg/dl). The cut-off point for the triglyceride difference was de-
termined by the median. 
 Biochemical analyses 
 At baseline and 3 h after the high-fat meal, blood samples were 
obtained from the antecubital vein and placed in vacutainer 
tubes (BD vacutainer™, London, UK). The serum was separated 
by centrifugation for 10 min at 4,000 rpm and frozen at   80°C 
until analysis. Data recorded for all subjects were age, weight, 
height (to calculate the BMI, calculated as the weight in kg di-
vided by the height in square meters), and waist and hip circum-
ferences (to calculate the waist-to-hip ratio, calculated as the 
waist circumference divided by the hip circumference). Serum 
glucose, uric acid, cholesterol, triglycerides, HDL cholesterol, 
free-fatty acids, C-reactive protein (CRP) and transaminases were 
measured in a Dimension autoanalyzer (Dade Behring Inc., 
Deerfi eld, IL) by enzymatic methods (Randox Laboratories Ltd., 
UK). Insulin levels were quantifi ed by radioimmunoassay sup-
plied by BioSource S.A. (Nivelles, Belgium). The LDL cholesterol 
was calculated from the Friedewald equation. The insulin resis-
tance was calculated from the homeostasis model assessment of 
insulin resistance (HOMA-IR) with the formula: insulin resis-
tance = [fasting serum insulin (  U/ml) × fasting blood glucose 
(mmol/L)]/22.5 ( 20 ). Leptin was analyzed by ELISA kits (DSL, 
Webster, TX). Adiponectin was analyzed by ELISA kits (DRG 
Diagnostics GmbH, Germany). Superoxide dismutase (SOD) 
activity was measured in plasma using commercial kits (Cayman 
Chemical, Ann Arbor, MI). 
 Chylomicrons were separated from serum by ultracentrifuga-
tion at 30,000 rpm for 30 min at room temperature (Beckman 
TLA 100.3). The top layer was carefully isolated and resuspended 
in endotoxin-free saline solution to the initial volume. 
 LAL assays 
 Serum LPS and chylomicron LPS concentrations were mea-
sured by endotoxin assay, based on a Limulus amebocyte extract with 
a chromogenic Limulus amebocyte lysate (LAL) assay (QCL-1000, 
Lonza Group Ltd.). Samples were diluted in pyrogen-free water 
 Fig.  1. Baseline and postprandial plasma superoxide dismutase 
activity in the four study groups. Results are presented as means ± 
SD. Different letters indicate signifi cant differences between the 
study groups (ANOVA, Bonferroni test). * P < 0.05 between base-
line and postprandial values. Group 1: patients with HOMA-IR   5 
and   TG < 80 mg/dl; Group 2: patients with HOMA-IR > 8 and 
  TG < 80 mg/dl; Group 3: patients with HOMA-IR   5 and   TG > 
80 mg/dl; Group 4: patients with HOMA-IR > 8 and   TG > 80 mg/dl. 
SOD, superoxide dismutase. 
 Fig.  2. Baseline and postprandial serum and chylomicron LPS 
levels in the four study groups. Results are presented as means ± 
SD. *  P < 0.05 between baseline and postprandial values; Group 1: 
patients with HOMA-IR   5 and   TG < 80 mg/dl; Group 2: pa-
tients with HOMA-IR > 8 and   TG < 80 mg/dl; Group 3: patients 
with HOMA-IR   5 and   TG > 80 mg/dl; Group 4: patients with 
HOMA-IR > 8 and   TG > 80 mg/dl. LPS, lipopolysaccharide; CM, 
chylomicron. 
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LDL-C, gamma-glutamyl transferase (GGT) , and CRP], 
and variables that correlated signifi cantly with LPS levels 
( Table 3 ). This analysis confi rmed that the baseline tri-
glyceride level was the best variable to predict the baseline 
serum LPS level. In addition, triglyceride levels at 0 h and 
3 h were signifi cantly and independently associated with 
LPS levels after fat overload. 
 A multiple regression analysis was also done with chylo-
micron LPS levels at 0 h and 3 h as dependent variables 
and the same independent variables as described above. 
The   TG was the only variable signifi cantly and indepen-
dently associated with chylomicron LPS at 3 h ( Table 4 ). 
In contrast, no signifi cant association was found with chy-
lomicron LPS levels at 0 h.  
 DISCUSSION 
 The results of this study show that a fat overload leads to 
increased LPS levels related with chylomicrons. This in-
crease was associated with postprandial hypertriglyceri-
demia but not with insulin resistance in morbidly obese 
patients. 
 The degree of metabolic endotoxemia is related to fat 
ingestion and some authors have suggested that it might 
be responsible, at least in part, for the low-grade infl am-
mation observed in obese patients ( 7, 18 ). However, to 
date, all studies dealing with endotoxemia and fat intake 
have been carried out in healthy lean subjects ( 7, 14 ). 
Thus, ours is the fi rst study to examine this hypothesis in 
morbidly obese patients and to attempt to clarify the rela-
tionship between metabolic endotoxemia, hypertriglyceri-
demia, and insulin resistance in obesity. 
 The intestinal microfl ora is considered a source of 
circulating LPS ( 9 ). In fact, small amounts of LPS are 
 No differences were seen between the study groups in 
baseline plasma SOD activity, but after fat overload, this 
was signifi cantly lower in the groups with   TG>80 mg/dl. 
After the fat overload, there was a signifi cant drop in SOD 
activity in all the groups, signifi cantly more pronounced in 
the groups with   TG>80 mg/dl ( Fig. 1 ). 
 Although groups 3 and 4 appear to have lower serum 
LPS levels, no signifi cant differences were found between 
groups at 0 h or 3 h in either serum or chylomicron LPS 
levels; only the groups with the highest   TG had a signifi -
cant increase over baseline after fat overload in both se-
rum and chylomicron LPS levels ( Fig. 2 ). 
 Plasma LPS levels at 0 h correlated positively with tri-
glyceride levels at 0 h. In addition, plasma LPS levels at 3 h 
correlated positively with triglyceride levels at both 0 h and 
3 h, and with plasma glucose levels. Chylomicron LPS lev-
els at 3 h as well as Delta chylomicron LPS (  CM LPS; 
measured as the difference between postprandial chylomi-
cron LPS and baseline chylomicron LPS levels) showed a 
positive correlation with the   TG ( Table 2 ). Infl ammatory 
(CRP) and hormonal (adiponectin and leptin) variables 
as well as anthropometric variables (BMI, waist, and age) 
showed no signifi cant correlations with LPS levels (data 
not shown). 
 We carried out a multiple regression analysis with those 
factors associated with serum LPS levels at 0 h and 3 h. We 
considered as independent variables age, sex, BMI, vari-
ables with signifi cant differences between the study 
groups in univariate analysis [waist circumference, insu-
lin, HOMA-IR, triglyceride levels,   TG, uric acid, HDL-C, 
 TABLE 3. Multiple linear regression analysis with serum LPS levels 
at both 0 h and 3 h after the fat overload as the dependent variables, 
in all the study subjects 
Serum LPS 0 h ( R = 0.480; R 2 = 0.230)
  P 95% CI
TG 0 h 0.480 0.013 0.000–0.001
Serum LPS 3 h ( R = 0.885; R 2 = 0.783)
  P 95% CI
TG 0 h 0.483 0.015   0.001–0.003
TG 3 h 0.407 0.033 0.000–0.002
TG, triglycerides. Independent variables: Triglycerides 0 h, 
Triglycerides 3 h,   TG (difference between postprandial and baseline 
triglyceride levels), HOMA-IR, insulin, glucose, body mass index, C-reactive 
protein, age, sex, waist circumference, uric acid, HDL-C, LDL-C and 
GGT.
 TABLE 2. Correlations between baseline and postprandial LPS levels in all the study subjects 
TG 0 h TG 3 h   TG Insulin HOMA-IR Glucose
LPS S 0 h 0.480 a 0.374   0.257   0.060 0.008 0.283
LPS S 3 h 0.852 b 0.837 b   0.180   0.069 0.063 0.442 a 
  LPS S 0.416 a 0.489 a 0.042   0.016 0.056 0.188
LPS CM 0 h   0.048 0.170 0.371 0.098 0.071   0.022
LPS CM 3 h   0.045 0.192 0.401 a   0.009   0.032   0.008
  LPS QM   0.041 0.192 0.394 a   0.053   0.072   0.001
Correlations were determined by Spearman’s correlation coeffi cient test. LPS, lipopolysaccharide; S, serum; 
CM, chylomicron; TG, triglycerides;   TG, difference between postprandial and baseline triglyceride levels; HOMA-
IR, Homeostasis model assessment of insulin resistance.
 a   P < 0.05.
 b P < 0.01.
 TABLE 4. Multiple linear regression analysis with chylomicron LPS 
levels at 3 h after the fat overload as the dependent variable, in all the 
study subjects 
Chylomicron LPS 3 h ( R = 0.401; R 2 = 0.161)
  P 95% CI
  TG 0.401 0.047 0.000-0.009
TG, triglycerides. Independent variables: Triglycerides 0 h, 
Triglycerides 3 h,   TG, (difference between postprandial and baseline 
triglyceride levels), HOMA-IR, insulin, glucose, body mass index, 
C-reactive protein, age, sex, waist circumference, uric acid, HDL-C, 
LDL-C and GGT.
Postprandial endotoxemia in morbid obesity 977
 Studies in mice showed a link between postprandial 
endotoxemia and postprandial hypertriglyceridemia when 
comparing the groups of mice fed with different diets 
( 11, 18 ). Our study shows that the postprandial triglycer-
ide level was more infl uential than the degree of insulin 
resistance in postprandial LPS levels and that serum LPS 
rose signifi cantly after fat overload only in morbidly obese 
patients displaying the highest triglyceride increase after 
a fatty meal. It is worth noting, though, that despite the 
lack of a signifi cant difference between groups in fasting 
LPS levels, the serum LPS increase might be driven by 
lower baseline LPS levels in groups 3 and 4. Interestingly, 
we found that the baseline triglyceride level was the vari-
able that best predicted the baseline LPS level in serum. 
This shows a clear relationship between triglyceride me-
tabolism and endotoxemia, though further studies will be 
necessary to elucidate what other mechanisms related to 
triglyceride metabolism, apart from chylomicrons, could 
be determining fasting endotoxemia. 
 The specifi c mechanisms leading to insulin resistance 
have been partially characterized and have revealed 
an incomplete picture of a complex cross-talk integrat-
ing metabolic, nutritional, and infl ammatory signaling 
pathways, eventually leading to the development of obe-
sity-induced insulin resistance ( 26 ). Among the various 
nutritional factors involved in the development of insu-
lin resistance, postprandial hypertriglyceridemia-associ-
ated increased endotoxemia could be responsible for a 
higher oxidative stress increase and the degree of in-
fl ammation that infl uences the insulin signaling path-
ways. Cani et al. ( 18 ) showed that LPS-infused mice had 
higher glucose and insulin levels than control mice, sug-
gesting that LPS could initiate insulin resistance and the 
development of diabetes. However, here we show that in 
morbidly obese patients, LPS levels are associated with 
triglyceride levels but not the degree of insulin resistance. 
 A noteworthy fi nding is that chylomicron LPS values 
were slightly higher than serum values, a result previously 
reported by other authors ( 13, 14 ). It would be expected 
that chylomicron LPS levels were lower than (or at most 
the same as) serum LPS levels. It has been previously re-
ported that certain proteins in serum could interfere with 
LAL enzymatic reaction ( 27 ) in spite of using heating to 
eliminate serum complement factor or dispersant agents. 
Thus, a plausible explanation for these discrepancies be-
tween serum and chylomicron LPS levels could be that 
LAL reaction-interfering serum molecules were not iso-
lated in the chylomicron fraction during ultracentrifuga-
tion and they stayed in the remaining fraction. 
 In conclusion, LPS levels rose after a fat overload in 
morbidly obese persons and those patients with a high 
postprandial triglyceride increase showed a higher in-
crease in chylomicron LPS levels after the fat overload as 
well as higher oxidative stress.  
 The authors thank all the subjects for their collaboration, 
and IMABIS. We also gratefully acknowledge the help of Ian 
Johnstone for his expertise in preparing this manuscript and 
Juan Alcaide-Torres for his technical contribution. 
absorbed from the gut in healthy animals ( 12 ) and bioac-
tived LPS is detectable in low amounts in the blood of 
healthy human subjects, even in the apparent absence of 
infections ( 21, 22 ). Chylomicrons have been associated 
with metabolic endotoxemia. Both animal and in vitro 
studies have demonstrated that chylomicron formation 
promotes LPS absorption ( 13 ). A recent study has also 
shown human chylomicrons can be postprandial carriers 
of LPS in healthy humans ( 14 ). 
 Our study agrees with the idea of chylomicron LPS 
transport because the patients with higher increases in 
triglyceride levels over baseline displayed higher levels of 
chylomicron LPS after the fat overload. Concordantly with 
the idea that chylomicrons promote LPS absorption, a 
high-fat meal leads to increased endotoxemia in healthy 
humans ( 7, 14 ). In consequence, it has been hypothesized 
that endogenous LPS levels could be responsible for the 
low-grade infl ammation observed in obese subjects who 
have a high fat intake. 
 Obesity is now considered to be a condition that facili-
tates the development of a low-grade infl ammatory state, 
characterized by increased plasma levels of proinfl amma-
tory cytokines such as tumor necrosis factor   , interleukins 
(IL), and cytokine-like proteins known as adipokines ( 4 ). 
It has been reported that patients with morbid obesity 
have a greater postprandial response to fat overload, and 
the postprandial response is associated with a greater 
increase in oxidative stress and infl ammation ( 8, 23 ). Bac-
terial endotoxin is increasingly being considered as a po-
tential infl ammatory mediator of obesity, diabetes, and 
atherosclerosis ( 10, 17, 24, 25 ). Laugerette et al. ( 14 ) 
showed that healthy subjects following a mixed meal con-
taining lipids from different food products undergo a 
transient increase in endotoxemia associated with raised 
infl ammation biomarkers such as sCD14 and an early peak 
of IL-6. Others have reported postprandial endotoxemia 
in healthy humans after a fat load (50 g of butter on toast) 
but failed to observe postprandial infl ammation ( 7 ). We 
found no relationship between CRP levels and LPS levels 
in our patients. In fact, CRP seems to be more related to 
obesity or insulin resistance. This agrees with previous 
studies fi nding no relationship between CRP and endotox-
emia or postprandial response ( 7 ). This is probably be-
cause CRP is a marker of long-term infl ammation rather 
than short-term infl ammation (which is the situation we 
studied in the postprandial state 3 h after fat load), and 
this may also explain the differences found in CRP levels 
according to the degree of insulin resistance but not to 
postprandial response. Clarifying the relationship between 
obesity and metabolic endotoxemia will require further 
studies exploring this association in obese patients. How-
ever, we did fi nd that patients with high triglyceride in-
creases after fat overload showed a decrease in antioxidant 
defenses because they had lower postprandial SOD activity 
than the patient groups with lower triglyceride increases 
after fat overload. Thus, these results show for the fi rst 
time a possible link between oxidative stress and metabolic 
endotoxemia. 
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